Search results for:
lecanemab
lecanemab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Lecanemab-irmb |
SOLUTION, INTRAVENOUS |
100 mg/mL (5 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lecanemab-irmb |
SOLUTION, INTRAVENOUS |
100 mg/mL (2 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Mar. 1, 2024
UNC Health
System Formulary Restriction:
Use of lecanemab injection is restricted to outpatient/clinic encounters only (i.e., no inpatient use) in patients who meet the following criteria: